Press release
Radiopharmaceutical CDMO/CMO Services Market Key Players Analysis - PharmaLogic, Eckert & Ziegler, AtomVie, Eczacıbaşı-Monrol.
Radiopharmaceutical CDMO/CMO Services Market
Global Radiopharmaceutical CDMO/CMO Services Market 2025-2034 full Research Repot latest version is now available.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2472
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global radiopharmaceutical CDMO/CMO services market are:
• Growing prevalence of cancer
• Growing interest in personalized treatment
• Technological advancements
The following are the primary obstacles to the radiopharmaceutical CDMO/CMO services market's expansion:
• High cost
• Inadequate infrastructure
• Shortages of skilled workers
Future expansion opportunities for the global radiopharmaceutical CDMO/CMO services market include:
• Growing use of nuclear therapy in underdeveloped nations
• Increasing investments in research and development
• Increased partnership with pharmaceutical industries
Key Industry Insights & Findings from the report:
• The market is growing rapidly due to supportive government initiatives and technological advancements.
• The market for radiopharmaceutical CDMO/CMO services is driven by the increasing incidence of cancer and pharmaceutical firms outsourcing manufacturing to save costs and comply with regulations.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• High costs and lack of infrastructure are major issues impeding industry expansion.
Market Analysis:
The market for radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services is being propelled by the rising prevalence of cardiovascular diseases and cancer, coupled with an increasing demand for nuclear therapies and advancements in radiopharmaceutical treatments. In addition, government support, higher research and development investments, and the evolution of medical imaging applications are contributing to the market's growth. Furthermore, the demand for customized medicines and the continued need for tailored medications are further driving the expansion of the radiopharmaceutical contract production and development services market.
List of Prominent Players in the Radiopharmaceutical CDMO/CMO Services Market:
• Minerva Imaging
• Evergreen Theragnostics, Inc.
• NMR (NorthStar Medical Radioisotopes
• PharmaLogic
• Eckert & Ziegler
• AtomVie
• Eczacıbaşı-Monrol
• Cardinal Health
• Nucleus RadioPharma
• Seibersdorf Labor GmbH
• Global Medical Solutions
• SOFIE
• SpectronRx
• Agilera Pharma AS
• Siemens Healthineers
• Grupo RPH
• Almac Group
• Medi-Radiopharma
• Itm Radiopharma
• Nihon Medi-Physics Co., Ltd.
• IONETIX Corporation
• GBI
• DuchemBio, Co., Ltd
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Recent Developments:
• In February 2024, the clinical-stage radiopharmaceutical company Evergreen Theragnostics, Inc. announced that it has partnered and licensed with the Medical University of Innsbruck, a preeminent European research institution, to promote the development of innovative radiopharmaceuticals.
• In February 2025, Lantheus Holdings, Inc. announced a definitive agreement to acquire Evergreen Theragnostics, Inc. ("Evergreen") in an all-cash transaction that includes a $250 million upfront payment and up to an additional $752.5 million in potential milestone payments. The company is dedicated to helping clinicians Find, Fight, and Follow disease to improve patient outcomes.
• In October 2024, Atley Solutions delivered and installed the first commercial unit at Minerva Imaging's facilities in Denmark, following the regulatory approval and launch of the world's first commercial module for making Astatine-211 (At-211) radiopharmaceuticals. With the release of the Atley C100, Atley Solutions has achieved a major technical and business milestone, solidifying its position as a world leader in commercial products and services for At-211 radiopharmaceuticals.
Radiopharmaceutical CDMO/CMO Services Market Dynamics:
Market Drivers: Technological Advancements
The growth of the radiopharmaceutical CDMO/CMO services market is primarily driven by technological advancements, including innovations in AI-driven imaging, automated radiopharmaceutical manufacturing, and the development of nuclear medicine technologies. Advances in drug formulations, new isotopes, and personalized radiotherapies are enhancing treatment accuracy and effectiveness. Additionally, improvements in quality assurance, regulatory compliance, and radiopharmaceutical synthesis are accelerating production processes, further fueling market growth.
Challenges: High Costs
The market for radiopharmaceutical CDMO/CMO services is constrained by high costs associated with raw materials, complex production processes, and stringent regulatory requirements. The short half-life of radioisotopes necessitates specialized facilities and intricate logistics, which further increases operational expenses. Additionally, the capital-intensive nature of radiopharmaceutical production, requiring highly trained personnel, radiation safety protocols, and advanced quality control systems, limits both market accessibility and growth.
Regional Outlook: North America
The North American radiopharmaceutical CDMO/CMO services market is expected to experience significant growth, registering the highest compound annual growth rate (CAGR) during the forecast period. This growth is driven by increased demand for nuclear medicine, a rise in cardiovascular and cancer cases, and substantial investments in radiopharmaceutical research and development. The region's advanced healthcare infrastructure, coupled with government support and regulatory approvals, further facilitates market expansion. Additionally, the presence of leading pharmaceutical companies, specialized CMOs, and ongoing advancements in targeted radiotherapies will continue to propel market growth in North America.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2472
Segmentation of Radiopharmaceutical CDMO/CMO Services Market-
By Application-
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
By Type of Radioisotope-
• Technetium-99m
• Fluorine-18
• Leutetium-177
• Gallium-68
• Actinium-225
• Others
By Source of Manufacturing-
• Nuclear Reactors
• Cyclotrons
By Scale of Operation-
• Preclinical
• Clinical
• Commercial
By Therapeutic Area-
• Cardiovascular Disorders
• Neurological Disorders
• Oncological Disorders
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/radiopharmaceutical-cdmocmo-services-market/2472
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical CDMO/CMO Services Market Key Players Analysis - PharmaLogic, Eckert & Ziegler, AtomVie, Eczacıbaşı-Monrol. here
News-ID: 4001248 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Minimally Invasive Fascial Closure Device Market Exclusive Report on the Latest …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Minimally Invasive Fascial Closure Device Market - (by Type (Winged Structure, Shield Structure) by Application (Hospital, Clinic)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Minimally Invasive Fascial Closure Device Market is valued at US$ 331.2 Mn in 2023, and it is expected to reach…
Mineral Fertilizers Market Report Latest Trends and Future Opportunities Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Mineral Fertilizers Market- (By Nutrient type (Nitrogen, Phosphate, Potash), By Crop Type (Oilseeds, Cereals, Fruits, Vegetables, Others), By Application Method (Foliar Spray, Fertigation, Drop Spreading/Placement, Broadcasting)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Mineral Fertilizers Market Size is valued at USD 114.7 Mn in…
Microbiome Manufacturing Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microbiome Manufacturing Market - (by Type of Product Manufactured (API and FDF), Type of Formulation (Solid, Liquid and Others), Type of Primary Packaging Used (Blister Packs, Glass / Plastic Bottles, Pouches / Sachets and Vials), Scale of Operation (Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large)), Trends, Industry Competition Analysis, Revenue…
Microbiology Reagents Market Deep Research Report with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microbiology Reagents Market - (By Type (Testing Reagent, Staining Reagent, Culture Medium, Antibiotic Solution, Others), By Type of Reagent (Silica gel, Agar Powder, Gelatin Powder and Others), By Product Type (Pathogen Specific Kits, General Kits), By End User Industry (Healthcare, Pharmaceuticals, Food & Beverage, Agriculture, Cosmetics, Clinical Microbiology, Academia, Others)), Trends, Industry Competition Analysis, Revenue…
More Releases for CMO
Healthcare Cmo Market Size Analysis by Application, Type, and Region: Forecast t …
USA, New Jersey- According to Market Research Intellect, the global Healthcare Cmo market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The healthcare contract manufacturing organization (CMO) market is witnessing steady expansion due to increasing demand for outsourced pharmaceutical and medical device production. Rising healthcare costs…
New Fractional CMO Agency Offers Fractional CMO Services to Businesses of All Si …
Modern CMO, a new fractional CMO agency, has officially launched to offer businesses of all sizes access to expert-level marketing strategies and a team of experienced CMOs to lead their marketing initiatives.
Modern CMO's fractional CMO services provide businesses with access to the same level of expertise as a full-time CMO, without the costly overhead expenses. This means that businesses can tap into Modern CMO's pool of highly skilled marketing professionals…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
